Abiraterone acetate: a potential source of interference in testosterone assays.

Fairfax BP., Morgan RD., Protheroe A., Shine B., James T.

DOI

10.1515/cclm-2017-0631

Type

Journal article

Journal

Clin Chem Lab Med

Publication Date

24/05/2018

Volume

56

Pages

e138 - e140

Keywords

abiraterone acetate, prostate cancer, testosterone, Abiraterone Acetate, Antineoplastic Agents, Artifacts, Cohort Studies, Cytochrome P-450 Enzyme Inhibitors, Humans, Immunoassay, Limit of Detection, Male, Mass Spectrometry, Prostatic Neoplasms, Testosterone

Permalink Original publication